Monday, September 28, 2026
  • Login
CEO North America
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
CEO North America
No Result
View All Result

CEO NA Magazine > News > CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims

CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims

in News
CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims
Share on LinkedinShare on WhatsApp

CVS Health, Walgreens Boots Alliance and Walmart have agreed to pay about $13.8 billion to resolve thousands of lawsuits accusing the pharmacy chains of mishandling opioid painkillers.

In a filing with the Securities and Exchange Commission Walgreens disclosed that it had agreed to pay about $5.7 billion over 15 years. CVS said Wednesday it had agreed to pay about $5 billion over 10 year and Walmart has agreed to pay $3.1 billion, according to two people familiar with the matter.

Neither company admitted wrongdoing.

CVS, Walgreens and Walmart are the three largest retail pharmacies in the country by market share.

“We are pleased to resolve these longstanding claims and putting them behind us is in the best interest of all parties, as well as our customers, colleagues and shareholders,” CVS’s general counsel, Thomas Moriarty, said in a statement. The company did not admit wrongdoing.

Walgreens said in its SEC filing that it “continues to believe it has strong legal defenses” and will defend itself against any future lawsuits not covered by the settlement.

In more than 3,300 lawsuits, beginning in 2017, state and local governments accused drugmakers of downplaying the risks of their opioid pain medicines. Pharmacies were accused of ignoring red flags that prescriptions were being diverted into illegal trafficking.

Overdoses involving opioids, including prescription pills and heroin, surged further during the Covid pandemic, increasing 38% in 2020 over the previous year and another 15% in 2021, according to the Centers for Disease Control and Prevention.

Tags: CVS HealthopioidsWalgreensWalmart

Related Posts

Five key takeaways from earnings season
News

Dollar falls following Trump, Xi meeting

Akamai shares jump 20% following $11.6 billion Anthropic deal
News

Akamai shares jump 20% following $11.6 billion Anthropic deal

Southwest reaches new contract with pilots
News

Oil falls as Iran offers to reopen Strait of Hormuz within 7 days

Lowe’s sales increase over 10% despite slow housing market
News

Lowe’s launches drone delivery service with DoorDash and Alphabet

SoftBank raises $11.1 billion in record high-yield bond sale
News

SoftBank raises $11.1 billion in record high-yield bond sale

Beijing calls tariffs “blackmail”
News

China hints at truce extension following trade talks

International Energy Agency says Iran war has caused historic oil market disruption
News

Oil sits near two-week low as diesel hits record high

Analyst: Not cutting rates will be an ’embarrassment’ for Fed
News

Fed warns inflation could be ‘notably’ higher after rate hike

GM reshapes product strategy with plug-in hybrid EVs
News

GM CEO Mary Barra to attend White House dinner for Xi

Novo Nordisk strikes deal with Hims & Hers to sell Wegovy and Ozempic
News

Novo Nordisk CEO defends diversification strategy

No Result
View All Result

Recent Posts

  • The GenAI Divide: Who’s Using ChatGPT to Save Time at Home
  • The new management playbook for AI: How to move faster and create more value
  • Stretches to Do Before Bed
  • Dollar falls following Trump, Xi meeting
  • Akamai shares jump 20% following $11.6 billion Anthropic deal

Archives

Categories

  • Art & Culture
  • Business
  • CEO Interviews
  • CEO Life
  • Editor´s Choice
  • Entrepreneur
  • Environment
  • Food
  • Health
  • Highlights
  • Industry
  • Innovation
  • Issues
  • Management & Leadership
  • News
  • Opinion
  • PrimeZone
  • Printed Version
  • Technology
  • Travel
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 2125 9933 0330

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

  • News
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 2125 9933 0330

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

CEO North America © 2024 - Sitemap

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.